Elevai Labs (ELAB) Competitors $2.60 +0.02 (+0.78%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.50 -0.10 (-3.81%) As of 04/17/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELAB vs. BGXX, CLRB, GLYC, SPRB, MBRX, LPTX, MRKR, NXTC, ABVC, and PHXMShould you be buying Elevai Labs stock or one of its competitors? The main competitors of Elevai Labs include Bright Green (BGXX), Cellectar Biosciences (CLRB), GlycoMimetics (GLYC), Spruce Biosciences (SPRB), Moleculin Biotech (MBRX), Leap Therapeutics (LPTX), Marker Therapeutics (MRKR), NextCure (NXTC), ABVC BioPharma (ABVC), and PHAXIAM Therapeutics (PHXM). These companies are all part of the "pharmaceutical products" industry. Elevai Labs vs. Bright Green Cellectar Biosciences GlycoMimetics Spruce Biosciences Moleculin Biotech Leap Therapeutics Marker Therapeutics NextCure ABVC BioPharma PHAXIAM Therapeutics Bright Green (NASDAQ:BGXX) and Elevai Labs (NASDAQ:ELAB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability. Which has higher earnings & valuation, BGXX or ELAB? Elevai Labs has higher revenue and earnings than Bright Green. Elevai Labs is trading at a lower price-to-earnings ratio than Bright Green, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright GreenN/AN/A-$13.13M-$0.06N/AElevai Labs$2.45M0.75-$4.30M-$433.87-0.01 Is BGXX or ELAB more profitable? Bright Green has a net margin of 0.00% compared to Elevai Labs' net margin of -223.41%. Bright Green's return on equity of -88.37% beat Elevai Labs' return on equity.Company Net Margins Return on Equity Return on Assets Bright GreenN/A -88.37% -55.30% Elevai Labs -223.41%-124.93%-85.10% Does the media refer more to BGXX or ELAB? In the previous week, Elevai Labs had 2 more articles in the media than Bright Green. MarketBeat recorded 2 mentions for Elevai Labs and 0 mentions for Bright Green. Bright Green's average media sentiment score of 0.00 beat Elevai Labs' score of -0.50 indicating that Bright Green is being referred to more favorably in the media. Company Overall Sentiment Bright Green Neutral Elevai Labs Negative Which has more risk & volatility, BGXX or ELAB? Bright Green has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Comparatively, Elevai Labs has a beta of -1.23, indicating that its share price is 223% less volatile than the S&P 500. Does the MarketBeat Community favor BGXX or ELAB? Bright Green and Elevai Labs both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBright GreenN/AN/AElevai LabsN/AN/A Do institutionals & insiders have more ownership in BGXX or ELAB? 7.8% of Bright Green shares are held by institutional investors. Comparatively, 22.2% of Elevai Labs shares are held by institutional investors. 62.5% of Bright Green shares are held by insiders. Comparatively, 0.6% of Elevai Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryBright Green beats Elevai Labs on 7 of the 12 factors compared between the two stocks. Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAB vs. The Competition Export to ExcelMetricElevai LabsPharmaceutical IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$1.84M$6.46B$12.46B$7.35BDividend YieldN/A3.21%3.84%4.34%P/E Ratio-0.046.959.4017.82Price / Sales0.75231.013.8497.72Price / CashN/A65.6713.3534.64Price / Book0.065.931.883.98Net Income-$4.30M$143.22M$959.43M$247.81M7 Day Performance-15.31%4.28%-0.98%3.19%1 Month Performance-59.38%-13.11%-7.05%-7.70%1 Year Performance-99.68%-8.51%-5.74%1.49% Elevai Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELABElevai Labs0.4547 of 5 stars$2.60+0.8%N/A-99.7%$1.84M$2.45M-0.0418Short Interest ↑BGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownCLRBCellectar Biosciences2.2453 of 5 stars$0.25-6.5%$12.50+4,954.6%-90.1%$11.40MN/A-0.1410Analyst ForecastShort Interest ↓News CoverageGLYCGlycoMimetics1.8973 of 5 stars$0.18-2.1%N/A-88.4%$11.37M$10,000.000.0050Analyst ForecastNews CoverageSPRBSpruce Biosciences2.7705 of 5 stars$0.27-2.5%$2.50+813.4%-83.1%$11.31M$7.10M-0.2920Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap DownMBRXMoleculin Biotech2.0984 of 5 stars$0.79-3.9%$17.33+2,099.4%-81.2%$11.03MN/A0.0020Short Interest ↑Gap DownLPTXLeap Therapeutics1.5363 of 5 stars$0.29+10.0%$4.92+1,582.6%-87.0%$10.96MN/A-0.1540Short Interest ↑Gap DownMRKRMarker Therapeutics3.2566 of 5 stars$1.01+1.0%$13.17+1,203.6%-72.2%$10.82M$3.31M-0.8460News CoverageNXTCNextCure4.1936 of 5 stars$0.39-1.1%$3.50+807.2%-77.4%$10.81MN/A-0.1890ABVCABVC BioPharma0.8343 of 5 stars$0.83+11.9%N/A-13.6%$10.77M$509,788.00-0.9730Earnings ReportGap UpHigh Trading VolumePHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049 Related Companies and Tools Related Companies BGXX Alternatives CLRB Alternatives GLYC Alternatives SPRB Alternatives MBRX Alternatives LPTX Alternatives MRKR Alternatives NXTC Alternatives ABVC Alternatives PHXM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ELAB) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevai Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevai Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELAB Stock Free ELAB Stock Alerts